Meghan R Flanagan

9PUBLICATIONS
0CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 03, 2025
ASO Visual Abstract: A Multi-institutional Analysis of Contralateral Axillary Metastases-Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.

Meghan R Flanagan, Astrid M Botty van den Bruele, Stephanie M Downs-Canner

|Jun 02, 2025
ASO Author Reflections: Contralateral Axillary Lymph Node Metastasis of Breast Cancer: Time to Re-evaluate Conventional Thinking.

Astrid Botty van den Bruele, Laura H Rosenberger, Stephanie Downs-Canner

|May 20, 2025
A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.

Meghan R Flanagan, Astrid M Botty van den Bruele, Stephanie M Downs-Canner

|Nov 06, 2022
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.

Nina M Clark, Emma A Roberts, Catherine Fedorenko

|Nov 02, 2022
ASO Author Reflections: Low Genetic Testing Utilization Among Patients with Breast, Ovarian, Pancreatic, and Prostate Cancers.

Nina M Clark, Meghan R Flanagan

|Jul 12, 2022
ASO Author Reflections: Inheritance of Adrenal Permissive HSD3B1 Genotype Negatively Impacts Outcomes in Hormone Receptor-Positive Postmenopausal Breast Cancer.

Meghan R Flanagan, Nima Sharifi, Vijayakrishna K Gadi

Pageof 2

Frequent Collaborators